Phase II Study Evaluating the Efficacy and Safety of the Combination of Tagraxofusp and Venetoclax in Treatment-naive Blastic Plasmacytoid Dendritic Cell Neoplasm Patients
Clinical trial NCT07007052 · RECRUITING
Trial details
- NCT number
- NCT07007052
- Sponsor
- French Innovative Leukemia Organisation
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-11
- Primary completion
- 2028-12-10
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.